» Articles » PMID: 36339446

The Roles of Mesenchymal Stem Cell-derived Exosomes in Diabetes Mellitus and Its Related Complications

Overview
Specialty Endocrinology
Date 2022 Nov 7
PMID 36339446
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes mellitus is a type of metabolic disease characterized by hyperglycemia, primarily caused by defects in insulin secretion, insulin action, or both. Long-term chronic hyperglycemia can lead to diabetes-related complications, causing damage, dysfunction, and failure of different organs. However, traditional insulin and oral drug therapy can only treat the symptoms but not delay the progressive failure of pancreatic beta cells or prevent the emergence of diabetic complications. Mesenchymal stem cells have received extensive attention due to their strong immunoregulatory functions and regeneration effects. Mesenchymal stem cell-derived exosomes (MSC-Exos) have been proposed as a novel treatment for diabetic patients as they have demonstrated superior efficiency to mesenchymal stem cells. This review summarizes the therapeutic effects, mechanisms, challenges, and future prospects of MSC-Exos in treating diabetes mellitus and its related complications. This review supports the potential use of MSC-Exos in future regenerative medicine to overcome the current difficulties in clinical treatment, particularly in treating diabetes.

Citing Articles

Applying adipose tissue-derived stem cell therapies as a novel treatment for atherosclerotic plaque development: Importance of appropriate dosing.

Allen M, Park S J Mol Cell Cardiol Plus. 2025; 10():100086.

PMID: 39801802 PMC: 11708246. DOI: 10.1016/j.jmccpl.2024.100086.


Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy.

Song Y, Yin C, Kong N Int J Nanomedicine. 2024; 19:10767-10784.

PMID: 39469447 PMC: 11514697. DOI: 10.2147/IJN.S475234.


Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis.

Kim B, Ronaldo R, Kweon B, Yoon S, Park Y, Baek J Int J Mol Sci. 2024; 25(19).

PMID: 39408777 PMC: 11476820. DOI: 10.3390/ijms251910447.


Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.

Azhar Ud Din M, Wan A, Chu Y, Zhou J, Yan Y, Xu Z Front Med (Lausanne). 2024; 11:1406547.

PMID: 39139783 PMC: 11319305. DOI: 10.3389/fmed.2024.1406547.


Stem Cell-Based Acellular Therapy: Insight into Biogenesis, Bioengineering and Therapeutic Applications of Exosomes.

Choudhery M, Arif T, Mahmood R, Harris D Biomolecules. 2024; 14(7).

PMID: 39062506 PMC: 11275160. DOI: 10.3390/biom14070792.


References
1.
Wang Z, Xie Z, Lu Q, Chang C, Zhou Z . Beyond Genetics: What Causes Type 1 Diabetes. Clin Rev Allergy Immunol. 2016; 52(2):273-286. DOI: 10.1007/s12016-016-8592-1. View

2.
Guillamat-Prats R . The Role of MSC in Wound Healing, Scarring and Regeneration. Cells. 2021; 10(7). PMC: 8305394. DOI: 10.3390/cells10071729. View

3.
Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J . Engineered Human Adipose Stem-Cell-Derived Exosomes Loaded with miR-21-5p to Promote Diabetic Cutaneous Wound Healing. Mol Pharm. 2020; 17(5):1723-1733. DOI: 10.1021/acs.molpharmaceut.0c00177. View

4.
Yap S, Tan K, Abd Rahaman N, Hamid N, Ooi D, Tor Y . Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats. Pharmaceutics. 2022; 14(3). PMC: 8948940. DOI: 10.3390/pharmaceutics14030649. View

5.
Wang C, Wang M, Xu T, Zhang X, Lin C, Gao W . Engineering Bioactive Self-Healing Antibacterial Exosomes Hydrogel for Promoting Chronic Diabetic Wound Healing and Complete Skin Regeneration. Theranostics. 2019; 9(1):65-76. PMC: 6332800. DOI: 10.7150/thno.29766. View